Conference Spotlight Posts
Conference Spotlight
2020 FDA Combination Products Policy and Guidance Changes
Jerry Chapman
January 14, 2021
Conference Spotlight
FDA OMQ Regulatory Actions Increase Dramatically in FY2020
Jerry Chapman
January 5, 2021
Conference Spotlight
Ashley Boam on FDA’s Proposed Quality Maturity Model
Jerry Chapman
December 22, 2020
Conference Spotlight
Chinese Pharmacopoeia 2020 Includes Updated Chapters in Key Areas
Rebecca Stauffer
December 17, 2020
Conference Spotlight
FDA’s Vision for the Future of Biomanufacturing
Jerry Chapman
December 16, 2020
Conference Spotlight
89 Products Filed as NDAs Now BLAs Under Regulation Change
Jerry Chapman
December 16, 2020
Conference Spotlight
Overcoming the Quality Challenges of a CAR-T Cell Product: One Company’s Experience
Jerry Chapman
December 10, 2020
Conference Spotlight
Impact of Brexit on UK & Northern Ireland Medical Device Regulations
Jerry Chapman
December 9, 2020
Conference Spotlight
FDA Cracks Down on Unapproved HCT Products
Jerry Chapman
December 3, 2020